Dartmouth researchers discover new mechanism of acquired resistance to breast cancer drugs

(The Geisel School of Medicine at Dartmouth) In the search for new approaches to treat ERBB2 -- also known as HER2 -- positive breast cancers that have become drug-resistant, Dartmouth investigator Manabu Kurokawa, Ph.D., led a team in discovery of a novel cancer resistance mechanism.